Cytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis

Cytokine

Volumn 75, Issue 2, 2015, Pages 216-221

  Taneja, Veena ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

Cytokines; MHC; Positive selection; Transgenic mice

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HLA DQ8 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; HLA DQ ANTIGEN; HLA DRB1 ANTIGEN; HLA-DRB1*04:01 ANTIGEN; IL17A PROTEIN, HUMAN; INTERLEUKIN 17;

ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENETIC POLYMORPHISM; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR4 ANTIGEN; HLA-DRB1 CHAINS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; POLYMORPHISM, GENETIC; TH1 CELLS; TH17 CELLS;

EID: 84939774856     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.11.028     Document Type: Article

References (49)

1. Ebringer A., Rashid T., Wilson C. Rheumatoid arthritis, proteus, anti-CCP antibodies and Karl Popper. Autoimmun Rev 2010, 9:216-223.
2. Boyle L.H., Hill J.S. Gaston, breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies. Rheumatology (Oxford) 2003, 42:404-412.
3. Yan Z.H., Fan Y., Wang X.H., Mao Q., Deng G.H., Wang Y.M. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis. World J Gastroenterol 2012, 18:3119-3128.
4. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517.
5. Gill N., Finlay B.B. The gut microbiota: challenging immunology. Nat Rev Immunol 2011, 11:636-637.
6. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine 2008, 41:84-91.
7. Brennan F.M., McInnes I.B. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545.
8. Thursz M., Yallop R., Goldin R., Trepo C., Thomas H.C. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999, 354:2119-2124.
9. Lundberg K., Wegner N., Yucel-Lindberg T., Venables P.J. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 2010, 6:727-730.
10. Christophorou M.A., Castelo-Branco G., Halley-Stott R.P., Oliveira C.S., Loos R., Radzisheuskaya A., et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 2014, 507:104-108.
11. Makrygiannakis D., af Klint E., Lundberg I.E., Lofberg R., Ulfgren A.K., Klareskog L., et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006, 65:1219-1222.
12. Moscarello M.A., Wood D.D., Ackerley C., Boulias C. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 1994, 94:146-154.
13. Vossenaar E.R., Smeets T.J., Kraan M.C., Raats J.M., van Venrooij W.J., Tak P.P. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheumatism 2004, 50:3485-3494.
14. Astry B., Harberts E., Moudgil K.D. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res 2011, 31:927-940.
15. Snir O., Rieck M., Gebe J.A., Yue B.B., Rawlings C.A., Nepom G., et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis rheumatism 2011, 63:2873-2883.
16. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996, 14:397-440.
17. Nishimoto N., Kishimoto T. Interleukin 6: from bench to bedside, nature clinical practice. Rheumatology 2006, 2:619-626.
18. Mima T., Nishimoto N. Clinical value of blocking IL-6 receptor. Curr Opin Rheumatol 2009, 21:224-230.
19. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999, 103:1345-1352.
20. Lubberts E., Joosten L.A., Oppers B., van den Bersselaar L., Coenen-de Roo C.J., Kolls J.K., et al. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 2001, 167:1004-1013.
21. Behrens M., Trejo T., Luthra H., Griffiths M., David C.S., Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmunity 2010, 35:1-9.
22. Taneja V., Behrens M., Mangalam A., Griffiths M.M., Luthra H.S., David C.S. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheumatism 2007, 56:69-78.
23. Hitchon C.A., Alex P., Erdile L.B., Frank M.B., Dozmorov I., Tang Y., et al. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatology 2004, 31:2336-2346.
24. Levy Y., Brouet J.C. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994, 93:424-428.
25. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
26. Davis J.M., Knutson K.L., Strausbauch M.A., Crowson C.S., Therneau T.M., Wettstein P.J., et al. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheumatism 2011, 63:1497-1506.
27. Scally S.W., Petersen J., Law S.C., Dudek N.L., Nel H.J., Loh K.L., et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med 2013, 210:2569-2582.
28. Hill J.A., Bell D.A., Brintnell W., Yue D., Wehrli B., Jevnikar A.M., et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008, 205:967-979.
29. Behrens M., Trejo T., Luthra H., Griffiths M., David C.S., Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmunity 2010, 35:1-9.
30. Luckey D., Behrens M., Smart M., Luthra H., David C.S., Taneja V. DRB1*0402 may influence arthritis by promoting naive CD4 T-cell differentiation in to regulatory T cells. Eur J Immunol 2014.
31. De Almeida D.E., Ling S., Pi X., Hartmann-Scruggs A.M., Pumpens P., Holoshitz J. Immune dysregulation by the rheumatoid arthritis shared epitope. J Immunol 2010, 185:1927-1934.
32. Taneja V., Taneja N., Behrens M., Pan S., Trejo T., Griffiths M., et al. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J Immunol 2003, 171:4431-4438.
33. Taneja V., David C.S. Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. Immunol Rev 2010, 233:62-78.
34. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003, 171:6173-6177.
35. Irmler I.M., Gajda M., Brauer R. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol 2007, 179:6228-6236.
36. Taneja V., Behrens M., Basal E., Sparks J., Griffiths M.M., Luthra H., et al. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol 2008, 181:2869-2877.
37. Cutolo M. Sex and rheumatoid arthritis: mouse model versus human disease. Arthritis Rheumatism 2007, 56:1-3.
38. Bouman A., Schipper M., Heineman M.J., Faas M.M. Gender difference in the non-specific and specific immune response in humans. Am J Reprod Immunol 2004, 52:19-26.
39. Giron-Gonzalez J.A., Moral F.J., Elvira J., Garcia-Gil D., Guerrero F., Gavilan I., et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000, 143:31-36.
40. Meyer J.M., Han J., Singh R., Moxley G. Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am J Hum Genet 1996, 58:371-383.
41. Jawaheer D., Lum R.F., Gregersen P.K., Criswell L.A. Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheumatism 2006, 54:3087-3094.
42. Taneja V., Taneja N., Paisansinsup T., Behrens M., Griffiths M., Luthra H., et al. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 2002, 168:5867-5875.
43. Taneja V., Krco C.J., Behrens M.D., Luthra H.S., Griffiths M.M., David C.S. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol 2007, 44:2988-2996.
44. Sinha S., Kaler L.J., Proctor T.M., Teuscher C., Vandenbark A.A., Offner H. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J Immunol 2008, 180:2679-2685.
45. Roden A.C., Moser M.T., Tri S.D., Mercader M., Kuntz S.M., Dong H., et al. Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 2004, 173:6098-6108.
46. Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., Siiteri P.K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978, 147:1568-1583.
47. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002, 109:1625-1633.
48. Cutolo M., Capellino S., Sulli A., Serioli B., Secchi M.E., Villaggio B., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci 2006, 1089:538-547.
49. Tengstrand B., Carlstrom K., Fellander-Tsai L., Hafstrom I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 2003, 30:2338-2343.